Stevens Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,390
| Closed | -$208K | – | 221 |
|
|
2024
Q1 | $208K | Buy |
+1,390
| New | +$208K | 0.04% | 262 |
|
|
2019
Q3 | – | Sell |
-14,571
| Closed | -$1.06M | – | 546 |
|
|
2019
Q2 | $1.06M | Buy |
+14,571
| New | +$1.06M | 0.05% | 358 |
|
|
2018
Q4 | – | Sell |
-7,041
| Closed | -$616K | – | 680 |
|
|
2018
Q3 | $616K | Buy |
+7,041
| New | +$616K | 0.02% | 500 |
|
|
2016
Q4 | – | Sell |
-15,286
| Closed | -$1.04M | – | 852 |
|
|
2016
Q3 | $1.04M | Buy |
+15,286
| New | +$1.04M | 0.04% | 403 |
|
|
2016
Q2 | – | Sell |
-11,168
| Closed | -$701K | – | 883 |
|
|
2016
Q1 | $701K | Buy |
+11,168
| New | +$701K | 0.03% | 499 |
|
|
2015
Q3 | – | Sell |
-4,603
| Closed | -$552K | – | 961 |
|
|
2015
Q2 | $552K | Buy |
4,603
+467
| +11% | +$56K | 0.02% | 592 |
|
|
2015
Q1 | $432K | Sell |
4,136
-8,894
| -68% | -$929K | 0.02% | 621 |
|
|
2014
Q4 | $1.26M | Buy |
+13,030
| New | +$1.26M | 0.04% | 372 |
|
|
2014
Q3 | – | Sell |
-49,810
| Closed | -$3.15M | – | 975 |
|
|
2014
Q2 | $3.15M | Buy |
49,810
+40,595
| +441% | +$2.56M | 0.08% | 270 |
|
|
2014
Q1 | $619K | Buy |
+9,215
| New | +$619K | 0.02% | 601 |
|